Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829760 · ClinicalTrials.gov registry record · NA
The Effect of Psyllium and Wheat Bran on Body Weight in People With Parkinson's Disease and Constipation Symptoms
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04829760 is a NA study that has completed, run by University of Florida. The registered enrollment target is 35 participants.
The verdict
NCT04829760, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is a 10-week randomized, controlled study to compare the safety and efficacy of two common fiber supplements, psyllium and wheat bran in terms of changes in body weight, nutrition status, and bowel function in patients with Parkinson's Disease who have constipation symptoms. After a 2-week run-in period, participants will be randomized to receive 10 grams daily of psyllium, coarse wheat bran, or maltodextrin (placebo) for 8 weeks. Nutritional and neurological evaluations will be conducted at the beginning and end of the 8-week intervention period.
Interventions
- DIETARY_SUPPLEMENT Maltodextrin
- DIETARY_SUPPLEMENT Psyllium
- DIETARY_SUPPLEMENT Coarse wheat bran
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-05-13 |
| Est. Completion | 2024-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04829760
The ClinicalTrials.gov registry entry for NCT04829760 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Maltodextrin is the first listed.
NCT04829760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04829760 about?
NCT04829760 is a clinical study titled "The Effect of Psyllium and Wheat Bran on Body Weight in People With Parkinson's Disease and Constipation Symptoms". This is a 10-week randomized, controlled study to compare the safety and efficacy of two common fiber supplements, psyllium and wheat bran in terms of changes in body weight, nutrition status, and bowel function in patients with Parkinson's Disease who have constipation symptoms. After a 2-week run-...
What is the current status of trial NCT04829760?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2021-05-13. Estimated completion is 2024-04-28.
What interventions are being tested in trial NCT04829760?
The interventions under investigation include: Maltodextrin (DIETARY_SUPPLEMENT), Psyllium (DIETARY_SUPPLEMENT), Coarse wheat bran (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04829760?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.